Search Results 621-630 of 17241 for coq10
Tumor Development, Immunology & Progression Lab of Peter Storz, Ph.D., at Mayo Clinic: Signaling pathways regulating breast cancer invasion & metastasis.
About this study. This is a multicenter, first-in-human (FIH), open label, Phase 1 dose escalation and recommended Phase 2 dose (RP2D) extension trial with ...
Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter Springer, Ph.D., is identifying novel mitophagy regulators and ...
Mayo Clinic researcher Muhib Khan, M.B.B.S., is a neurologist studying the treatment of acute stroke as it relates to imaging, therapy and recovery.
The purpose of this study is to investigate the seroprevalence of pre-existing immunity to adenovirus-associated virus (AAV) in patients with myosin binding ...
This is a single-arm, open label, proof of concept (PoC) study of Cenicriviroc (CVC) in adult subjects with Primary Sclerosing Cholangitis (PSC). The main ...
The purpose of this study is to demonstrate a reduction in lung function decline as measured by the change from baseline in Forced Vital Capacity (FVC) for BI ...
Mayo Clinic's top-ranked Pulmonary Medicine Division diagnoses and treats more than 65,000 adults and children with lung (pulmonary) and sleep disorders ...
Sioda NA, Armstrong VL, Madura G, Laitinen MA, Lim ES, Chang YH, Harold K, Pearson D, Elli E, Kellogg T, Madura JA. 22-year experience with bariatric ...
About this study. The primary objective of this trial is to determine the effect of GB002 on improving pulmonary hemodynamics in subjects with World Health ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.